Octarine bio
Octarine bio
Bio-based dye palette that replaces conventional synthetic dyes
Investment vertical
- Biosolutionsabout /verticals/biosolutionsBiosolutions
Stage
- Seed
Website
www.octarinebio.com about https://www.octarinebio.com/The challenge
The textile industry, particularly conventional dyeing, is one of the most polluting industries globally. Its reliance on fossil-based synthetic dyes burdens the planet with high water and energy use, toxic chemical pollutants, and substantial greenhouse gas emissions. Finding vibrant, broad-spectrum colours that are environmentally friendly has long been a barrier, as natural dyes often lack the range, consistency, and scalability that fashion and textile supply chains demand.
The solution
Octarine Bio uses synthetic biology and precision fermentation to produce a bio-based dye palette that replaces conventional synthetic dyes. Their dyes are vibrant, scalable, and compatible with natural and synthetic fabrics, while reducing water use, energy consumption, CO₂ emissions, and toxicity. With Octarine’s nature-derived dyes, the textile industry can adopt sustainable colour solutions without compromising quality or scale.
Footprint team
- Anna Søndergaardabout ?overlay=anna-sondergaard
aso@thefootprintfirm.com about mailto:aso@thefootprintfirm.comAnna Søndergaard
Co-Founding Partner
Sofie brings a decade of experience in investment, corporate finance, and strategy. Having worked across private equity, growth capital, and venture capital, she has been deeply involved in investments, advisory boards, and sustainability initiatives. Before joining us, Sofie was part of the investment team at SEB Private Equity, where she was responsible for investing capital from top tier, third party institutions into private equity on a global scale in different structures. Sofie worked as a sparring partner, serving on the advisory board of top tier private equity firms and led numerous co-investments spanning private equity, growth capital and venture capital.
In the Nordics, Sofie led the acquisition and divestment of majority and significant minority investments and served on the board of companies like Planday, VaccinDirekt and Better Jusage. Additionally, her experience includes running mandates and raising external funds, as well as being a driver of the sustainability strategy and serving on the ESG Committee.
Academically, Sofie holds an MSc in Corporate Finance from Cass Business School (now Bayes Business School) in London and a BSc in Business Administration from Lund University (including a secondment at the University of Melbourne).